EUVIMEDEUVIMED entdecken
Crossref

Rapid on‐site evaluation (ROSE) of image‐guided FNA specimens improves subsequent core biopsy adequacy in clinical trial patients: The impact of preanalytical factors and its correlation with survival

Ashleigh J Graham, Mahalia T Robinson, Jessica Kahler, Javad R Azadi iD, Zahra Maleki iD

Cancer Cytopathology · 2024

DOI: 10.1002/cncy.22764 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cytopathology, 2024. Verfasst von Ashleigh J Graham und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Rapid On-site Evaluation, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sufficient tumor collection has become of utmost importance in therapeutic experimental protocols. Rapid on‐site evaluation (ROSE) ensures adequate sampling for quantification of biomarkers, molecular analyses, and other ancillary studies. The objectives of this study were to evaluate the role of ROSE in trial‐associated fine‐needle aspiration (FNA) and to analyze predictors of adequacy and cumulative survival from in‐house FNA cases used in clinical trials.

Methods

Clinical trial FNA biopsies performed at a large academic institution were analyzed over 10 months using a comprehensive chart review of the electronic medical records. SPSS version 28 was used for statistical analysis.

Results

Three hundred twenty‐five FNAs were collected for 57 clinical trials. In total, 225 individual patients had an average of 1.4 FNA procedures each as a result of a multidepartmental collaborative effort. ROSE was performed for all patients, and adequacy was evaluated by cytotechnologists. Seventy‐eight percent of samples were considered adequate, 14% were considered less than optimal, and 8% were considered inadequate, with the latter two categories designated together as less than adequate . The imaging modalities were mainly ultrasound‐guided ( n = 267; 82%) and computed tomography‐guided ( n = 58; 18%). There was a statistically significant association between adequate sampling and ultrasound‐guided biopsies (83%) compared with computed tomography‐guided biopsies (59%; p < .01). The effect of body mass index (BMI) on mortality was also a significant finding. The authors observed a survival benefit in patients who had elevated BMIs (range, 25.0–34.9 kg/m 2 ) compared with those who were underweight (BMI, 35.0 kg/m 2 ; p < .01). Therefore, the best predictors of adequacy and mortality were imaging modality and BMI, respectively.

Conclusions

Ultrasound‐guided modalities are recommended for obtaining adequate FNA sampling for clinical trials. In addition, patients with cancer who had slightly elevated BMIs (25.0–34.0 kg/m 2 ) had increased overall survival in this cohort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rapid On-site EvaluationNeoplasmsHumansBiopsy, Fine-NeedleBiopsy, Large-Core NeedleImage-Guided BiopsyEndoscopic Ultrasound-Guided Fine Needle AspirationRetrospective Studies

Stichwörter der Autor:innen

clinical trialscore biopsiespreanalytical factorsrapid on-site evaluationsurvival

Autor:innen und Institutionen

  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Javad R Azadi, Zahra Maleki

Zitieren

APA

Graham, A. J., Robinson, M. T., Kahler, J., Azadi, J. R., & Maleki, Z. (2024). Rapid on‐site evaluation (ROSE) of image‐guided FNA specimens improves subsequent core biopsy adequacy in clinical trial patients: The impact of preanalytical factors and its correlation with survival. Cancer Cytopathology. https://doi.org/10.1002/cncy.22764

Vancouver

Graham AJ, Robinson MT, Kahler J, Azadi JR, Maleki Z. Rapid on‐site evaluation (ROSE) of image‐guided FNA specimens improves subsequent core biopsy adequacy in clinical trial patients: The impact of preanalytical factors and its correlation with survival. Cancer Cytopathology. 2024. doi:10.1002/cncy.22764

BibTeX
@article{Graham2024,
  author = {Graham, Ashleigh J and Robinson, Mahalia T and Kahler, Jessica and Azadi, Javad R and Maleki, Zahra},
  title = {Rapid on‐site evaluation (ROSE) of image‐guided FNA specimens improves subsequent core biopsy adequacy in clinical trial patients: The impact of preanalytical factors and its correlation with survival},
  journal = {Cancer Cytopathology},
  year = {2024},
  doi = {10.1002/cncy.22764}
}
Kostenlos starten →